GlassScriptPhysician profile
Mahit H Bhatt
NPI 1730564006
$5,028.94
in general payments reported to CMS, 2019-2025
12 companies · $317 in 2025
The $317 reported for 2025 was more than what 85% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $114 · 2021: $261 · 2022: $534 · 2023: $2,703 · 2024: $315 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,888 · Travel and Lodging: $1,320 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,887.81 |
| Travel and Lodging | $1,319.61 |
| Education | $127.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $3,461.16 | 2022-2025 | |
| Sirona Dental, INC. | $500.00 | 2019 | |
| Straumann USA LLC | $245.62 | 2019-2021 | |
| Keystone Dental INC. | $156.77 | 2022-2025 | |
| Dentsply Sirona INC | $148.22 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $135.86 | 2021 | |
| Geistlich Pharma, North America, INC. | $123.97 | 2025 | Biomaterials |
| Orapharma, A Division of Bausch Health US, LLC | $96.95 | 2019-2020 | |
| Align Technology, INC. | $83.47 | 2023-2025 | Invisalign, Invisalign Go |
| Solventum Corporation | $43.33 | 2024 | Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Scotchbond |
| Biolase, INC. | $17.35 | 2019 | |
| Kerr Corporation | $16.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahit Bhatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.